Skip to main content

Call for papers

Fibrosis and Cancer Intersection

We are welcoming submissions to our new collection on the intersection of fibrosis and cancer, guested edited by Mary Salvatore and Monica Pernia.

Submission Deadline: 1 October 2023

Planeterranean Diet

Submit to our new collection, "Planeterranean" Diet: Globally Extending the Health Benefits of the Mediterranean Diet, guest edited by Luigi Barrea, Salvatore Nesci, Prisco Piscitelli, Laura Soldati, and Claudia Vetrani.

Submission Deadline: 31 January 2024

Meet the Editors

Get to know the Editors behind Journal of Translational Medicine! 

Featured section: Neuroscience

The Neuroscience section aims to encourage publications that help to reduce the gap between basic preclinical science and medical applications for the patients in the neuroscience field. Any new tool for the dissemination of results in the field can greatly help to progress in the new solutions for the neuropsychiatric patient. The section aims to promote the increase of knowledge on the subject by publishing original research. 

Read the latest articles in the Neuroscience section

Featured Research: Interactions between MFAP5 + fibroblasts and tumor-infiltrating myeloid cells shape the malignant microenvironment of colorectal cancer

The therapeutic targeting of the tumor microenvironment (TME) in colorectal cancer (CRC) has not yet been fully developed and utilized because of the complexity of the cell–cell interactions within the TME. The further exploration of these interactions among tumor-specific clusters would provide more detailed information about these communication networks with potential curative value. This study elucidates the underlying pro-tumor mechanisms of tumor-resident MFAP5 + fibroblasts and provided valuable targets for the disruption of their properties.

Featured Review: Liquid biopsies: the future of cancer early detection

Despite being the second leading cause of death worldwide, many cancers do not have screening programs and many people with a high risk of developing cancer fail to follow the advised medical screening regime due to the nature of the available screening tests and other challenges with compliance. Moreover, many liquid biopsy strategies being developed for early detection of cancer lack the sensitivity required to detect early-stage cancers. Early detection is key for improved quality of life, survival, and to reduce the financial burden of cancer treatments which are greater at later stage detection. This review examines the current liquid biopsy market, focusing in particular on the strengths and drawbacks of techniques in achieving early cancer detection.

Articles

Journal of Translational Medicine has launched In Review, a new option that provides authors with on-demand information on the status of their manuscript, enables them to share their work with funders and their research community, and allows their colleagues to comment and collaborate - all whilst their manuscript is under review.

Read More

Journal News

Please note that Journal of Translational Medicine is no longer considering submissions of study protocols. 

Editor Spotlight

Section: Translational Metagenomics 

Selvasankar Murugesan, Ph.D., is the Senior Research fellow from the microbiome and biomarkers discovery laboratory at Sidra Medicine, Qatar. He focuses on human microbiome-based biomarker discovery to apply in precision medicine. He is an active member of the Mexican Microbiology association (AMM). In addition, he is an Associate Editor for the Journal of Translational Medicine. He holds a Ph.D. in Pharmacology from the Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Mexico, where he studied the role of the gut microbiome in childhood obesity.

View the previous 'Editor Spotlights' here

Meet the Editors

Get to know the Editors behind Journal of Translational Medicine! 

Top trending articles


Check out the most discussed articles from the previous month!

Our companion journal

Translational Medicine Communications. the companion journal to Journal of Translational Medicine, is an interdisciplinary forum for all scientifically valid research from across translational medicine. 

The journal aims to improve transparency and reproducibility within translational medicine and considers research papers regardless of outcome or significance of findings.

Explore Translational Medicine Communications

Introducing new sections to Journal of Translational Medicine!

Translational Process

© smolaw11 / stock.adobe.comLed by Marina Boccardi, the Translational Process section welcomes contributions aimed to streamline the transition of new knowledge along the translational continuum, and boost our ability to concretely innovate clinical practice. 

The Translational Process section dedicates a space to those who tackle such challenges overcoming the boundaries of individual disciplines, and offers a new opportunity to share and accelerate the development of urgently needed methods, tools and procedures. 

Reproductive Medicine & Clinical Reproductive Sciences

© Sebastian Kaulitzki / stock.adobe.comLed by Section Editor Matteo Alessandro Avella, the Reproductive Medicine & Clinical Reproductive Science section is focused on the basic mechanisms or the translational and clinical aspects of human reproductive biology. 

The section welcomes studies on preclinical and clinical studies whose results have the potential to prevent, diagnose, and treat reproductive issues, as well as studies that describe and characterize the genes and the mechanisms regulating human reproductive biology in cell line or animal models, and reviews on existing and novel technologies.

Cell Death and Senescence

© © ipopba / Getty Images / iStockLed by Section Editors Lorenzo Gullazzi and Melissa Myint, the Cell Death and Senescence section is focused on the dysfunctions in the molecular and cellular mechanisms through which individual eukaryotic cells respond to stress and interact with their host in the process. 

This section welcomes original research contributions, review articles, and commentaries discussing mechanistic and pathophysiological aspects of these processes.


Translational Ophthalmology

Led by Section Editors Geoffrey Broadhead and Levon Khachigian, the Translational Ophthalmology section is focused on the rapidly expanding field of translational medicine as it relates to ophthalmology and vision science, as well as the role of ophthalmology in guiding the diagnosis and care of other (non-ophthalmic) diseases.

The section welcomes studies on mechanisms and development of novel therapies for ophthalmic conditions, new biomarkers of ocular pathology, and the role of ophthalmology and ophthalmic findings in the diagnosis and management of systemic medical conditions.

Editor-in-Chief: Francesco Marincola, Sonata Therapeutics, USA

Franco Marincola is the Chief Scientific Officer of Sonata Therapeutics. Franco brings over 30 years of research and development experience in immunology, oncology and cell therapy to Sonata.

Most recently, Franco served as Senior Vice President and Global Head of Research at Kite Pharma where he led the research organization to identify novel therapies for hematologic malignancies and solid tumors. Prior to Kite, he was President and Chief Scientific Officer at Refuge Biotechnologies, where he developed research strategies for adoptive cell therapy products and led therapeutic programs based on nuclease deactivated CRISPR circuits. Prior to Refuge, Franco was Distinguished Research Fellow in Immune Oncology at AbbVie, and Chief Research Officer at Sidra Medical and Research Centre.

Before joining the biopharma industry, Franco spent more than two decades at the National Institutes of Health (NIH) and National Cancer Institute (NCI), most recently as a tenured senior investigator in cancer immunotherapy and biomarker research and as Chief Infectious Disease and Immunogenetics Investigator at the NIH Clinical Center.

Franco is the former President of the Society for Immunotherapy of Cancer (SITC). He currently serves as Editor-in-Chief for multiple peer-reviewed publications, including Journal of Translational Medicine, Translational Medicine Communications, and Immunotherapy, and is the author of more than 600 peer-reviewed publications.

Franco received his M.D. from the University of Milan and completed his residency at Stanford University.

Aims and scope

Journal of Translational Medicine is an open access journal publishing articles focusing on information derived from human experimentation so as to optimise the communication between basic and clinical science.

The journal covers all areas of translational medicine but also has several special sections:


Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    6.9 - 5-year Impact Factor
    1.458 - SNIP (Source Normalized Impact per Paper)
    1.544 - SJR (SCImago Journal Rank)

    2022 Speed
    5 days submission to first editorial decision for all manuscripts (Median)
    84 days submission to accept (Median)

    2022 Usage 
    4,243,080 downloads
    32,614 Altmetric mentions